Mitsubishi Tanabe Pharma
E554263
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Mitsubishi Tanabe Pharma canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T5887965 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Mitsubishi Tanabe Pharma Context triple: [Mitsubishi, hasMember, Mitsubishi Tanabe Pharma]
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
C.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
D.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
E.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Mitsubishi Tanabe Pharma Target entity description: Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
A.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
B.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
C.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
-
D.
Eisai
Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
-
E.
Sankyo Company
Sankyo Company is a Japanese pharmaceutical firm known for its role in developing cholesterol-lowering statin drugs and later becoming part of Daiichi Sankyo.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| alternativeName |
MTPC
NERFINISHED
ⓘ
Mitsubishi Tanabe Pharma Corporation NERFINISHED ⓘ |
| country | Japan ⓘ |
| engagesIn |
biologic drug development
ⓘ
clinical research ⓘ drug discovery ⓘ |
| focusesOn | research and development of innovative medicines ⓘ |
| foundedBy | Mitsubishi Chemical Holdings Group NERFINISHED ⓘ |
| hasResearchCenter |
Osaka research facilities
ⓘ
Yokohama research facilities ⓘ |
| hasSubsidiary |
Mitsubishi Tanabe Pharma America
NERFINISHED
ⓘ
Mitsubishi Tanabe Pharma Development America NERFINISHED ⓘ Mitsubishi Tanabe Pharma Europe NERFINISHED ⓘ |
| headquartersLocation |
Osaka
NERFINISHED
ⓘ
Tokyo ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| languageOfWorkOrName | Japanese ⓘ |
| legalForm | Kabushiki gaisha ⓘ |
| memberOf | Mitsubishi Group NERFINISHED ⓘ |
| notableProduct |
Radicava
NERFINISHED
ⓘ
Radicut NERFINISHED ⓘ edaravone NERFINISHED ⓘ |
| parentOrganization | Mitsubishi Chemical Group NERFINISHED ⓘ |
| predecessor |
Mitsubishi Pharma
NERFINISHED
ⓘ
Tanabe Seiyaku NERFINISHED ⓘ |
| product |
autoimmune disease treatments
ⓘ
biopharmaceuticals ⓘ cardiovascular drugs ⓘ diabetes drugs ⓘ neurology drugs ⓘ prescription drugs ⓘ vaccines ⓘ |
| regionServed |
Asia
ⓘ
Europe ⓘ Japan ⓘ North America ⓘ |
| stockExchange | Tokyo Stock Exchange NERFINISHED ⓘ |
| therapeuticArea |
autoimmune diseases
ⓘ
cardiovascular diseases ⓘ diabetes ⓘ neurology ⓘ |
| tickerSymbol | 4508 ⓘ |
| website | https://www.mt-pharma.co.jp ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Mitsubishi Tanabe Pharma Description of subject: Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.